FARAN is faithful to its vision and values, implementing its commitment to the Greek patient and the health system, offering renowned therapeutic proposals of high quality and therapeutic value for the treatment of cancer. FARAN’s therapeutic portfolio consists of original, biosimilar, as well as generic products, and covers a wide range of treatments against solid tumors.